{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:02:09Z","timestamp":1788868929535,"version":"build-2803163510"},"reference-count":51,"publisher":"Oxford University Press (OUP)","issue":"34","license":[{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100024598","name":"British Heart Foundation Data Science Centre","doi-asserted-by":"publisher","award":["SP\/19\/3\/34678"],"award-info":[{"award-number":["SP\/19\/3\/34678"]}],"id":[{"id":"10.13039\/501100024598","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and Aims<\/jats:title>\n                    <jats:p>Heart failure (HF) with preserved ejection fraction (HFpEF) constitutes a heterogeneous disease with varying prognosis. Given the rising incidence of HFpEF, accurate risk prediction for these patients is needed to identify high-risk individuals, who may benefit the most from preventive treatments. The LIFE-Preserved model was developed and validated for the prediction of individual short-term and lifetime risk for HF hospitalization or cardiovascular (CV) death in patients with HFpEF.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>LIFE-Preserved was derived in 20 332 patients aged 40\u201390 years with a left ventricular ejection fraction \u2265 50% from the Swedish HF Registry. Cause- and sex-specific Cox models were derived to predict the risk of HF hospitalization or CV death using 14 routinely available predictors. Use of age as the timescale allowed for predictions beyond the maximum follow-up duration in the derivation data, adjusted for competing risks. External validation was performed in two trials (EMPEROR-Preserved and TOPCAT-Americas) and three registries (NHS England Secure Data Environment, Veterans Affairs, and HF-Particles). Model performance was assessed by discrimination and calibration.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>During a median follow-up of 1.8 years (interquartile range .6\u20134.2, maximum 19 years), 9341 first HF hospitalizations or CV deaths (46%) were observed in Swedish HF Registry. External validation included data from 28 062 patients with HFpEF [9930 (35%) first HF hospitalizations or CV deaths]. Pooled C-statistics were .714 (95% confidence interval .652\u2013.775) in trials and .658 (95% confidence interval .599\u2013.717 in registries, with adequate calibration in all external validation sources. Performance was similar in men and women. An interactive calculator of the LIFE-Preserved model has been made available here.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The LIFE-Preserved model enables prediction of short-term and lifetime risk of HF hospitalization or CV death in patients with HFpEF. The model could serve as a tool to identify high-risk HFpEF patients, guiding clinical management and shared decision-making.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/eurheartj\/ehag182","type":"journal-article","created":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T12:40:08Z","timestamp":1771936808000},"page":"4773-4788","source":"Crossref","is-referenced-by-count":8,"title":["Risk prediction in patients with heart failure with preserved ejection fraction: the LIFE-Preserved model"],"prefix":"10.1093","volume":"47","author":[{"given":"Tessa H","family":"Reitsma","sequence":"first","affiliation":[{"name":"Department of Vascular Medicine and Endocrinology, University Medical Centre Utrecht , Utrecht 3508 ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7732-0887","authenticated-orcid":false,"given":"Gianluigi","family":"Savarese","sequence":"additional","affiliation":[{"name":"Department of Clinical Science and Education, S\u00f6dersjukhuset; Karolinska Institute , Stockholm ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0141ukasz","family":"Ku\u017ama","sequence":"additional","affiliation":[{"name":"Department of Invasive Cardiology, Medical University of Bia\u0142ystok , Bia\u0142ystok ,","place":["Poland"]},{"name":"Department of Cardiac Surgery and Transplantology, National Medical Institute of the Ministry of Interior , Warsaw ,","place":["Poland"]},{"name":"Liverpool Centre for Cardiovascular Science, University of Liverpool , Liverpool ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salil V","family":"Deo","sequence":"additional","affiliation":[{"name":"Surgical Services, Louis Stokes Cleveland VA Medical Center , Cleveland, OH ,","place":["USA"]},{"name":"Case School of Medicine, Case Western Reserve University School of Medicine , Cleveland, OH ,","place":["USA"]},{"name":"School of Health and Wellbeing, University of Glasgow , Glasgow ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8594-3061","authenticated-orcid":false,"given":"Lisa","family":"Pennells","sequence":"additional","affiliation":[{"name":"British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge , Cambridge ,","place":["UK"]},{"name":"Victor Phillip Dahdaleh Heart and Lung Research Institute, University of Cambridge , Cambridge ,","place":["UK"]},{"name":"British Heart Foundation Centre of Research Excellence, University of Cambridge , Cambridge ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven H J","family":"Hageman","sequence":"additional","affiliation":[{"name":"Department of Vascular Medicine and Endocrinology, University Medical Centre Utrecht , Utrecht 3508 ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7616-3839","authenticated-orcid":false,"given":"Joris","family":"Holtrop","sequence":"additional","affiliation":[{"name":"Department of Vascular Medicine and Endocrinology, University Medical Centre Utrecht , Utrecht 3508 ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5393-0055","authenticated-orcid":false,"given":"Lina","family":"Benson","sequence":"additional","affiliation":[{"name":"Department of Clinical Science and Education, S\u00f6dersjukhuset; Karolinska Institute , Stockholm ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Conrad","sequence":"additional","affiliation":[{"name":"Nuffield Department of Women\u2019s and Reproductive Health, University of Oxford , Oxford ,","place":["UK"]},{"name":"Department of Cardiovascular Sciences, KU Leuven , Leuven ,","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars H","family":"Lund","sequence":"additional","affiliation":[{"name":"Department of Medicine and KArolinska University Hospital, Department of Cardiology, Karolinska Institutet , Stockholm ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0526-3339","authenticated-orcid":false,"given":"Anna","family":"Kurasz","sequence":"additional","affiliation":[{"name":"Department of Invasive Cardiology, Medical University of Bia\u0142ystok , Bia\u0142ystok ,","place":["Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1155-4872","authenticated-orcid":false,"given":"Stephen","family":"Kaptoge","sequence":"additional","affiliation":[{"name":"British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge , Cambridge ,","place":["UK"]},{"name":"Victor Phillip Dahdaleh Heart and Lung Research Institute, University of Cambridge , Cambridge ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spencer J","family":"Keene","sequence":"additional","affiliation":[{"name":"British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge , Cambridge ,","place":["UK"]},{"name":"Victor Phillip Dahdaleh Heart and Lung Research Institute, University of Cambridge , Cambridge ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chimweta","family":"Chilala","sequence":"additional","affiliation":[{"name":"British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge , Cambridge ,","place":["UK"]},{"name":"Victor Phillip Dahdaleh Heart and Lung Research Institute, University of Cambridge , Cambridge ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matilda","family":"Pitt","sequence":"additional","affiliation":[{"name":"British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge , Cambridge ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A","family":"Fletcher","sequence":"additional","affiliation":[{"name":"British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge , Cambridge ,","place":["UK"]},{"name":"Victor Phillip Dahdaleh Heart and Lung Research Institute, University of Cambridge , Cambridge ,","place":["UK"]},{"name":"Health Data Research UK , London ,","place":["UK"]},{"name":"The George Institute for Global Health, University of New South Wales , Sydney ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2343-7099","authenticated-orcid":false,"given":"Kamlesh","family":"Khunti","sequence":"additional","affiliation":[{"name":"Diabetes Research Centre, Leicester General Hospital, University of Leicester , Leicester ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1124-234X","authenticated-orcid":false,"given":"Massimo","family":"Piepoli","sequence":"additional","affiliation":[{"name":"Department of Biomedical Science for Health, University of Milan , Milan ,","place":["Italy"]},{"name":"Clinical University Cardiology, IRCCS Policlinico San Donato , Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Rossello","sequence":"additional","affiliation":[{"name":"Hospital Universitario Son Espases, Health Research Institute of the Balearic Islands, Universitat Illes Balears , Palma de Mallorca ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6331-0178","authenticated-orcid":false,"given":"Jennifer S","family":"Lees","sequence":"additional","affiliation":[{"name":"School of Cardiovascular & Metabolic Health, University of Glasgow , Glasgow ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5976-6519","authenticated-orcid":false,"given":"Maryam","family":"Kavousi","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Erasmus MC, University Medical Centre Rotterdam , Rotterdam ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John William","family":"McEvoy","sequence":"additional","affiliation":[{"name":"School of Medicine and National Institute for Prevention and Cardiovascular Health, University of Galway , Galway ,","place":["Ireland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela M","family":"Wood","sequence":"additional","affiliation":[{"name":"British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge , Cambridge ,","place":["UK"]},{"name":"Victor Phillip Dahdaleh Heart and Lung Research Institute, University of Cambridge , Cambridge ,","place":["UK"]},{"name":"British Heart Foundation Centre of Research Excellence, University of Cambridge , Cambridge ,","place":["UK"]},{"name":"National Institute for Health and Care Research Blood and Transplant Research Unit in Donor Health and Behaviour, University of Cambridge , Cambridge ,","place":["UK"]},{"name":"Health Data Research UK Cambridge, Wellcome Genome Campus and University of Cambridge , Cambridge ,","place":["UK"]},{"name":"British Heart Foundation Data Science Centre, Health Data Research UK , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4775-9140","authenticated-orcid":false,"given":"Rudolf A","family":"de Boer","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Thorax Center, Cardiovascular Institute, Erasmus MC , Rotterdam ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Andersson","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Copenhagen University Hospital Herlev and Gentofte , Herlev ,","place":["Denmark"]},{"name":"Center for Advanced Heart Disease, Brigham and Women\u2019s Hospital and Harvard Medical School , Boston, MA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank L J","family":"Visseren","sequence":"additional","affiliation":[{"name":"Department of Vascular Medicine and Endocrinology, University Medical Centre Utrecht , Utrecht 3508 ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Koudstaal","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Thorax Center, Cardiovascular Institute, Erasmus MC , Rotterdam ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8776-6719","authenticated-orcid":false,"given":"Emanuele","family":"Di Angelantonio","sequence":"additional","affiliation":[{"name":"British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge , Cambridge ,","place":["UK"]},{"name":"Victor Phillip Dahdaleh Heart and Lung Research Institute, University of Cambridge , Cambridge ,","place":["UK"]},{"name":"National Institute for Health and Care Research Blood and Transplant Research Unit in Donor Health and Behaviour, University of Cambridge , Cambridge ,","place":["UK"]},{"name":"Health Data Research UK Cambridge, Wellcome Genome Campus and University of Cambridge , Cambridge ,","place":["UK"]},{"name":"Health Data Science Research Centre, Human Technopole , Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0190-8526","authenticated-orcid":false,"given":"Jannick A N","family":"Dorresteijn","sequence":"additional","affiliation":[{"name":"Department of Vascular Medicine and Endocrinology, University Medical Centre Utrecht , Utrecht 3508 ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the CVD-COVID-UK\/COVID-IMPACT Consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Angelantonio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Abreu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Visseren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Kavousi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John William","family":"McEvoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,3,11]]},"reference":[{"key":"2026090719580403100_ehag182-B1","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1002\/ejhf.1858","article-title":"Epidemiology of heart failure","volume":"22","author":"Groenewegen","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"2026090719580403100_ehag182-B2","doi-asserted-by":"publisher","first-page":"3272","DOI":"10.1093\/cvr\/cvac013","article-title":"Global burden of heart failure: a comprehensive and updated review of epidemiology","volume":"118","author":"Savarese","year":"2023","journal-title":"Cardiovasc Res"},{"key":"2026090719580403100_ehag182-B3","doi-asserted-by":"publisher","first-page":"e871","DOI":"10.1016\/S2468-2667(24)00215-9","article-title":"Contemporary epidemiology of hospitalised heart failure with reduced versus preserved ejection fraction in England: a retrospective, cohort study of whole-population electronic health records","volume":"9","author":"Fletcher","year":"2024","journal-title":"Lancet Public Health"},{"key":"2026090719580403100_ehag182-B4","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1056\/NEJMoa1908655","article-title":"Angiotensin-neprilysin inhibition in heart failure with preserved ejection fraction","volume":"381","author":"Solomon","year":"2019","journal-title":"N Engl J Med"},{"key":"2026090719580403100_ehag182-B5","doi-asserted-by":"publisher","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","article-title":"2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Heidenreich","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"2026090719580403100_ehag182-B6","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1056\/NEJMoa0805450","article-title":"Irbesartan in patients with heart failure and preserved ejection fraction","volume":"359","author":"Massie","year":"2008","journal-title":"N Engl J Med"},{"key":"2026090719580403100_ehag182-B7","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in heart failure with a preserved ejection fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N Engl J Med"},{"key":"2026090719580403100_ehag182-B8","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1056\/NEJMoa2407107","article-title":"Finerenone in heart failure with mildly reduced or preserved ejection fraction","volume":"391","author":"Solomon","year":"2024","journal-title":"N Engl J Med"},{"key":"2026090719580403100_ehag182-B9","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1056\/NEJMoa2206286","article-title":"Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction","volume":"387","author":"Solomon","year":"2022","journal-title":"N Engl J Med"},{"key":"2026090719580403100_ehag182-B10","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/S0140-6736(24)01643-X","article-title":"Semaglutide versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: a pooled analysis of the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM randomised trials","volume":"404","author":"Kosiborod","year":"2024","journal-title":"Lancet"},{"key":"2026090719580403100_ehag182-B11","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1056\/NEJMoa2410027","article-title":"Tirzepatide for heart failure with preserved ejection fraction and obesity","volume":"392","author":"Packer","year":"2025","journal-title":"N Engl J Med"},{"key":"2026090719580403100_ehag182-B12","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1002\/ejhf.2894","article-title":"Patient phenotype profiling in heart failure with preserved ejection fraction to guide therapeutic decision making. A scientific statement of the heart failure association, the European heart rhythm association of the European Society of Cardiology, and the European society of hypertension","volume":"25","author":"Anker","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"2026090719580403100_ehag182-B13","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1093\/eurheartj\/ehae002","article-title":"Cardiovascular disease risk communication and prevention: a meta-analysis","volume":"45","author":"Bakhit","year":"2024","journal-title":"Eur Heart J"},{"key":"2026090719580403100_ehag182-B14","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1093\/eurheartj\/ehi555","article-title":"Predictors of mortality and morbidity in patients with chronic heart failure","volume":"27","author":"Pocock","year":"2006","journal-title":"Eur Heart J"},{"key":"2026090719580403100_ehag182-B15","doi-asserted-by":"publisher","first-page":"e009594","DOI":"10.1161\/JAHA.118.009594","article-title":"Meta-analysis global group in chronic (MAGGIC) heart failure risk score: validation of a simple tool for the prediction of morbidity and mortality in heart failure with preserved ejection fraction","volume":"7","author":"Rich","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"2026090719580403100_ehag182-B16","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1161\/CIRCHEARTFAILURE.109.932996","article-title":"Factors associated with outcome in heart failure with preserved ejection fraction: findings from the irbesartan in heart failure with preserved ejection fraction study (I-PRESERVE)","volume":"4","author":"Komajda","year":"2011","journal-title":"Circ Heart Fail"},{"key":"2026090719580403100_ehag182-B17","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ijcard.2018.10.076","article-title":"The 3A3B score: the simple risk score for heart failure with preserved ejection fraction\u2014a report from the CHART-2 study","volume":"284","author":"Kasahara","year":"2019","journal-title":"Int J Cardiol"},{"key":"2026090719580403100_ehag182-B18","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1002\/ejhf.2607","article-title":"Biomarker-driven prognostic models in chronic heart failure with preserved ejection fraction: the EMPEROR-preserved trial","volume":"24","author":"Pocock","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"2026090719580403100_ehag182-B19","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1001\/jamacardio.2024.0284","article-title":"Prognostic models for mortality and morbidity in heart failure with preserved ejection fraction","volume":"9","author":"McDowell","year":"2024","journal-title":"JAMA Cardiol"},{"key":"2026090719580403100_ehag182-B20","doi-asserted-by":"publisher","first-page":"e70011","DOI":"10.1002\/bimj.70011","article-title":"Risk-based decision making: estimands for sequential prediction under interventions","volume":"66","author":"Luijken","year":"2024","journal-title":"Biom J"},{"key":"2026090719580403100_ehag182-B21","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC Guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur Heart J"},{"key":"2026090719580403100_ehag182-B22","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.009217","article-title":"Estimated life expectancy without recurrent cardiovascular events in patients with vascular disease: the SMART-REACH model","volume":"7","author":"Kaasenbrood","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"2026090719580403100_ehag182-B23","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1093\/eurheartj\/ehac056","article-title":"Estimation of recurrent atherosclerotic cardiovascular event risk in patients with established cardiovascular disease: the updated SMART2 algorithm","volume":"43","author":"Hageman","year":"2022","journal-title":"Eur Heart J"},{"key":"2026090719580403100_ehag182-B24","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1093\/eurheartj\/ehab309","article-title":"SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe","volume":"42","author":"Hageman","year":"2021","journal-title":"Eur Heart J"},{"key":"2026090719580403100_ehag182-B25","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1093\/eurjpc\/zwae174","article-title":"Prediction of individual lifetime cardiovascular risk and potential treatment benefit: development and recalibration of the LIFE-CVD2 model to four European risk regions","volume":"31","author":"Hageman","year":"2024","journal-title":"Eur J Prev Cardiol"},{"key":"2026090719580403100_ehag182-B26","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1002\/ejhf.3028","article-title":"Personalized lifetime prediction of survival and treatment benefit in patients with heart failure with reduced ejection fraction: the LIFE-HF model","volume":"25","author":"Burger","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"2026090719580403100_ehag182-B27","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1080\/03009734.2018.1490831","article-title":"The Swedish heart failure registry: a living, ongoing quality assurance and research in heart failure","volume":"124","author":"Savarese","year":"2019","journal-title":"Ups J Med Sci"},{"key":"2026090719580403100_ehag182-B28","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1007\/s00392-024-02498-z","article-title":"Modern heart failure treatment is superior to conventional treatment across the left ventricular ejection spectrum: real-life data from the Swedish heart failure registry 2013\u20132020","volume":"113","author":"Karlstr\u00f6m","year":"2024","journal-title":"Clin Res Cardiol"},{"key":"2026090719580403100_ehag182-B29"},{"key":"2026090719580403100_ehag182-B30","doi-asserted-by":"publisher","first-page":"100910","DOI":"10.1016\/j.lanepe.2024.100910","article-title":"Effect of air pollution exposure on risk of acute coronary syndromes in Poland: a nationwide population-based study (EP-PARTICLES study)","volume":"41","author":"Ku\u017ama","year":"2024","journal-title":"Lancet Reg Health Eur"},{"key":"2026090719580403100_ehag182-B31","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1002\/ejhf.2446","article-title":"Revascularization in ischaemic heart failure with preserved ejection fraction: a nationwide cohort study","volume":"24","author":"Deo","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"2026090719580403100_ehag182-B32","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1056\/NEJMoa1313731","article-title":"Spironolactone for heart failure with preserved ejection fraction","volume":"370","author":"Pitt","year":"2014","journal-title":"N Engl J Med"},{"key":"2026090719580403100_ehag182-B33","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"2026090719580403100_ehag182-B34","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1093\/eurjpc\/zwad202","article-title":"The relevance of competing risk adjustment in cardiovascular risk prediction models for clinical practice","volume":"30","author":"Hageman","year":"2023","journal-title":"Eur J Prev Cardiol"},{"key":"2026090719580403100_ehag182-B35","doi-asserted-by":"publisher","first-page":"i1548","DOI":"10.1136\/bmj.i1548","article-title":"How to translate clinical trial results into gain in healthy life expectancy for individual patients","volume":"352","author":"Dorresteijn","year":"2016","journal-title":"BMJ"},{"key":"2026090719580403100_ehag182-B36","doi-asserted-by":"publisher","first-page":"e009217","DOI":"10.1161\/JAHA.118.009217","article-title":"Estimated life expectancy without recurrent cardiovascular events in patients with vascular disease: the SMART-REACH model","volume":"7","author":"Kaasenbrood","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"2026090719580403100_ehag182-B37","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1093\/eurheartj\/ehz239","article-title":"Prediction of individualized lifetime benefit from cholesterol lowering, blood pressure lowering, antithrombotic therapy, and smoking cessation in apparently healthy people","volume":"41","author":"Jaspers","year":"2020","journal-title":"Eur Heart J"},{"key":"2026090719580403100_ehag182-B38","doi-asserted-by":"publisher","first-page":"2894","DOI":"10.1002\/ehf2.12899","article-title":"Trends in cause-specific readmissions in heart failure with preserved vs. Reduced and mid-range ejection fraction","volume":"7","author":"Cui","year":"2020","journal-title":"ESC Heart Fail"},{"key":"2026090719580403100_ehag182-B39","doi-asserted-by":"publisher","first-page":"e069249","DOI":"10.1136\/bmj-2021-069249","article-title":"Validation of prediction models in the presence of competing risks: a guide through modern methods","volume":"377","author":"van Geloven","year":"2022","journal-title":"BMJ"},{"key":"2026090719580403100_ehag182-B40","doi-asserted-by":"publisher","first-page":"i6460","DOI":"10.1136\/bmj.i6460","article-title":"A guide to systematic review and meta-analysis of prediction model performance","volume":"356","author":"Debray","year":"2017","journal-title":"BMJ"},{"key":"2026090719580403100_ehag182-B41","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.1093\/eurheartj\/ehy839","article-title":"Prediction of individual life-years gained without cardiovascular events from lipid, blood pressure, glucose, and aspirin treatment based on data of more than 500 000 patients with Type 2 diabetes mellitus","volume":"40","author":"Berkelmans","year":"2019","journal-title":"Eur Heart J"},{"key":"2026090719580403100_ehag182-B42","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/S2213-8587(24)00102-5","article-title":"Effect of SGLT2 inhibitors on heart failure outcomes and cardiovascular death across the cardiometabolic disease spectrum: a systematic review and meta-analysis","volume":"12","author":"Usman","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026090719580403100_ehag182-B43","doi-asserted-by":"publisher","first-page":"55","DOI":"10.7326\/M14-0697","article-title":"Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement","volume":"162","author":"Collins","year":"2015","journal-title":"Ann Intern Med"},{"key":"2026090719580403100_ehag182-B44","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/j.jclinepi.2006.01.014","article-title":"Review: a gentle introduction to imputation of missing values","volume":"59","author":"Donders","year":"2006","journal-title":"J Clin Epidemiol"},{"key":"2026090719580403100_ehag182-B45","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1161\/CIRCULATIONAHA.106.672402","article-title":"Use and misuse of the receiver operating characteristic curve in risk prediction","volume":"115","author":"Cook","year":"2007","journal-title":"Circulation"},{"key":"2026090719580403100_ehag182-B46","doi-asserted-by":"publisher","first-page":"e041673","DOI":"10.1136\/bmjopen-2020-041673","article-title":"Communicating personalised statin therapy-effects as 10-year CVD-risk or CVD-free life-expectancy: does it improve decisional conflict? Three-armed, blinded, randomised controlled trial","volume":"11","author":"Jaspers","year":"2021","journal-title":"BMJ Open"},{"key":"2026090719580403100_ehag182-B47","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jclinepi.2019.11.001","article-title":"Changing predictor measurement procedures affected the performance of prediction models in clinical examples","volume":"119","author":"Luijken","year":"2020","journal-title":"J Clin Epidemiol"},{"key":"2026090719580403100_ehag182-B48","doi-asserted-by":"publisher","first-page":"51","DOI":"10.7326\/M18-1376","article-title":"PROBAST: a tool to assess the risk of bias and applicability of prediction model studies","volume":"170","author":"Wolff","year":"2019","journal-title":"Ann Intern Med"},{"key":"2026090719580403100_ehag182-B49","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"2026090719580403100_ehag182-B50","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/s41569-021-00605-5","article-title":"Heart failure with mid-range or mildly reduced ejection fraction","volume":"19","author":"Savarese","year":"2022","journal-title":"Nat Rev Cardiol"},{"key":"2026090719580403100_ehag182-B51","author":"SwedeHF Heart Failure Registry"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/advance-article-pdf\/doi\/10.1093\/eurheartj\/ehag182\/67283316\/ehag182.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/47\/34\/4773\/67283316\/ehag182.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/47\/34\/4773\/67283316\/ehag182.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T23:58:09Z","timestamp":1788825489000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/47\/34\/4773\/8505998"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,11]]},"references-count":51,"journal-issue":{"issue":"34","published-online":{"date-parts":[[2026,3,11]]},"published-print":{"date-parts":[[2026,9,8]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehag182","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9,7]]},"published":{"date-parts":[[2026,3,11]]}}}